ArticleDrug and alcohol dependence2026
Comparison of statewide substance use disorder prevalence estimates from survey data vs electronic health record data.
Article in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPrevalence estimates for substance use disorders (SUD) in the United States are primarily based on the National Survey on Drug Use and Health (NSDUH) which often lags, making real-time interventions difficult. Electronic health record (EHR)-derived estimates can provide near real-time estimates. We aimed to compare EHR-based state-level estimates with those derived from the NSDUH survey.
methods2023 EHR SUD prevalence data from the Minnesota Electronic Health Record Consortium (MNEHRC), a network of health systems across Minnesota, were compared to 2023 NSDUH prevalence data for Minnesota.
resultsMNEHRC estimated alcohol use disorder (AUD) prevalence to be 3.80% while NSDUH reported 11.40%. MNEHRC prevalence for opioid use disorder (OUD) was 1.30% while NSDUH reported it as 1.76%. NSDUH reported a prevalence of 1.56% for cocaine use and 0.85% for methamphetamine use, while MNEHRC data found a prevalence of cocaine use of 0.32% and psychostimulant use of 0.83%. Age trends varied among the two methods. NSDUH estimated the highest substance use prevalence in the 18-25 age group with a decline in the > 26 group while MNEHRC showed an increasing prevalence with age for all substances.
conclusionEstimates of OUD and methamphetamine use prevalence were similar across the two approaches, whereas those for AUD and cocaine use differed. These findings suggest that EHR data may capture some substance use conditions accurately enough to proxy population level prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.